Welcome to MedArena!

Your trusted destination for CME, CPD & Medical Education across the Middle East.

Information

  • Address:MedArena Corporation
  • Call Us:1 (800) 828-2059
  • Email:support [at] medarenaevents.com
Dr. Awni Al Shurafa

Achievements

2023Certification from the European Hematology Association (EHA)
—Fellow and Specialist Physician in Hematology & Medical Oncology at Hamad Medical Corporation (HMC) in Doha, Qatar.
—Co-author of over 100 peer-reviewed clinical research articles on chronic myeloid leukemia, immune thrombocytopenia, and hematologic therapies.

Dr. Awni Al Shurafa

Specialist / Fellow Physician in Hematology & Medical Oncology

Hamad Medical Corporation (HMC), Doha, Qatar

About

Dr. Awni Al Shurafa is a Specialist and Fellow Physician in the Department of Hematology and Medical Oncology at Hamad Medical Corporation in Doha, Qatar. He earned his Medical Doctorate (MD) and completed comprehensive internal medicine residency training prior to undertaking specialized higher subspecialty fellowship training in clinical hematology and medical oncology across major tertiary teaching hospitals in Qatar.

In his clinical practice at Hamad General Hospital and the National Center for Cancer Care and Research (NCCCR), Dr. Al Shurafa specializes in managing both classical non-malignant hematologic disorders and hematologic malignancies. His clinical domains encompass immune thrombocytopenia (ITP), chronic myeloid leukemia (CML), non-Hodgkin lymphomas, bone marrow failure syndromes, and red blood cell disorders including sickle cell disease and complex anemias.

Dr. Al Shurafa is an active clinical researcher who has co-authored over 100 peer-reviewed scientific publications, book chapters, and research abstracts appearing in leading journals such as Blood, European Journal of Haematology, Frontiers in Hematology, and Cureus. His ongoing research investigates real-world responses to tyrosine kinase inhibitor (TKI) therapies, thrombopoietin receptor agonists, hepcidin dysregulation in chronic disease anemia, and management strategies for viral complications in hematology patients.

As an active faculty speaker for MeetingMinds Experts' regional educational platforms—including the International Conference of Classical Hematology (ICCH 2026)—Dr. Al Shurafa regularly presents original research findings, leads interactive clinical case discussions, and mentors junior clinicians. His academic efforts support the advancement of evidence-based classical hematology and the standardization of patient care practices across the Middle East.

Dr. Awni Alshurafa is a physician and clinical researcher affiliated with Hamad Medical Corporation (HMC) in Doha, Qatar. His professional work focuses on hematology, the medical specialty concerned with disorders of the blood, bone marrow, and lymphatic system. His research interests include sickle cell disease, anemia, blood cancers, myeloproliferative neoplasms, and the evaluation of treatments for complex hematologic conditions.

Dr. Alshurafa has been involved in clinical research examining the presentation, diagnosis, treatment, and outcomes of blood disorders. His work includes collaborative studies with physicians and researchers in Qatar and other institutions, contributing to the growing body of medical literature on hematologic diseases in the Middle East.

His research portfolio covers a broad range of topics, including sickle cell disease complications, chronic myeloid leukemia, immune thrombocytopenia, myeloproliferative neoplasms, and uncommon bleeding disorders. Through collaborative clinical studies, systematic reviews, and case reports, he has contributed to the documentation of treatment experiences and clinical outcomes in patients with these conditions.

A significant area of his research concerns sickle cell disease, an inherited blood disorder that can cause painful crises, chronic anemia, and complications affecting multiple organs. His work in this area includes publications examining avascular necrosis, leg ulcers, treatment-related complications, and emerging therapeutic approaches.

Dr. Alshurafa has also contributed to research on chronic myeloid leukemia and other hematologic malignancies, including studies of tyrosine kinase inhibitor therapy, treatment safety, and the management of patients with additional medical conditions. His research reflects an interest in improving understanding of treatment outcomes and supporting evidence-based clinical decision-making.

Through his professional affiliation with Hamad Medical Corporation and his research collaborations, Dr. Alshurafa contributes to clinical scholarship in hematology and the development of medical knowledge relevant to patients with complex blood disorders.

Current Institution and Professional Position

  • Institution: Hamad Medical Corporation.
  • Clinical department: Department of Medicine, Hamad General Hospital.
  • Location: Doha, Qatar.
  • Professional position: Medical Doctor; also listed as a Hematology Fellow in his professional research profile.

Education and Professional Training

Dr. Alshurafa is identified as a medical doctor. However, detailed information about his medical school, graduation year, postgraduate qualifications, and specialist certification was not sufficiently confirmed for inclusion in this profile.

Achievements and Research Contributions

  • Extensive hematology research portfolio: Has contributed to a substantial body of scientific publications addressing blood disorders, hematologic malignancies, and treatment outcomes.
  • Research on sickle cell disease: Co-authored studies examining complications such as avascular necrosis and leg ulcers, alongside research into emerging therapeutic approaches.
  • Contribution to chronic myeloid leukemia research: Participated in studies investigating tyrosine kinase inhibitor treatment, renal function, treatment safety, and patient outcomes.
  • Research on uncommon bleeding disorders: Co-authored a case report on severe Factor XI deficiency, contributing to the medical literature on the diagnosis of rare coagulation disorders.
  • Research on immune thrombocytopenia: Contributed to collaborative research examining treatment outcomes and clinical characteristics in patients with immune thrombocytopenia.
  • Work on myeloproliferative neoplasms: Participated in research reviewing disease characteristics, treatment strategies, and outcomes in patients with these bone marrow disorders.
  • Published case reports: Contributed to reports documenting complex clinical presentations, including hemoglobin Köln and complications associated with sickle cell disease.
  • Collaborative academic research: Worked with clinicians and researchers affiliated with Hamad Medical Corporation and other institutions on clinical studies, systematic reviews, and medical publications.
  • Contribution to regional hematology literature: Participated in research addressing blood disorders and treatment experiences in Qatar and the wider Middle East.

Areas of Research Interest

  • Clinical hematology
  • Sickle cell disease and its complications
  • Chronic myeloid leukemia
  • Myeloproliferative neoplasms
  • Immune thrombocytopenia
  • Anemia and hemoglobin disorders
  • Coagulation and bleeding disorders
  • Hematologic malignancies
  • Treatment safety and clinical outcomes

Selected Research Contributions

  • Research on the clinical and epidemiological characteristics of avascular necrosis in patients with sickle cell disease.
  • Studies investigating tyrosine kinase inhibitor treatment and kidney function in patients with chronic myeloid leukemia.
  • Case reports examining uncommon hemoglobin variants and inherited coagulation disorders.
  • Collaborative research on treatment-related complications and emerging therapies for sickle cell disease.
  • Reviews and studies concerning the diagnosis and management of myeloproliferative neoplasms.

Events & Activities

International Classical Hematology Conference 2026 | ICCH 2026
Dec 18, 2026
In-Person

International Classical Hematology Conference 2026 | ICCH 2026

MeetingMinds Experts

  • CME/CPD
  • Dusit Thani, Abu Dhabi, United Arab Emirates
Dec 18, 2026
In-Person

International Classical Hematology Conference 2026 | ICCH 2026

USD 150

The 1st International Conference of Classical Hematology (ICCH 2026) brings together regional and international experts in Abu Dhabi to explore the latest advancements, research, and innovations in classical hematology.

MeetingMinds Experts

  • 3 Days
  • Dusit Thani, Abu Dhabi, United Arab Emirates
CME Certified Courses
Medical Education Hub
Expert Medical Speakers
AI-Powered Learning
Accredited Certificates
Live Medical Events
Continuous Medical Education
CME Certified Courses
Medical Education Hub
Expert Medical Speakers
AI-Powered Learning
Accredited Certificates
Live Medical Events
Continuous Medical Education
CME Certified Courses
Medical Education Hub
Expert Medical Speakers
AI-Powered Learning
Accredited Certificates
Live Medical Events
Continuous Medical Education